Hakim Bouterfa
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Epidemiology top 2%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 17
- Neuroendocrine Tumor Research Advances 16
-
- Retinoids in leukemia and cellular processes 4
- Epigenetics and DNA Methylation 3
- Genomics and Chromatin Dynamics 3
- Co-authors
- K. Roosen (10 shared papers)Detlef Doenecke (7 shared papers)François Jamar (4 shared papers)Larry K. Kvols (4 shared papers)Raffaella Barone (4 shared papers)Roelf Valkema (3 shared papers)Eric P. Krenning (2 shared papers)Jens Kaufmann (6 shared papers)
- Journals
- Journal of Nuclear Medicine (3 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Journal of Neuro-Oncology (2 papers)Neurosurgery (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hakim Bouterfa
40 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 92
- Neurology 541
- Epidemiology 1.0k
- Oncology 825
- Endocrinology, Diabetes and Metabolism 360
- Radiology, Nuclear Medicine and Imaging 407
Countries citing papers authored by Hakim Bouterfa
This map shows the geographic impact of Hakim Bouterfa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Bouterfa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Bouterfa more than expected).
Fields of papers citing papers by Hakim Bouterfa
This network shows the impact of papers produced by Hakim Bouterfa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Bouterfa. The network helps show where Hakim Bouterfa may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakim Bouterfa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 235 | |
| 2 | 2010 | 226 | |
| 3 | 2003 | 177 | |
| 4 | 2007 | 159 | |
| 5 | 2017 | 129 | |
| 6 | 1999 | 126 | |
| 7 | 2017 | 113 | |
| 8 | Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. | 2000 | 112 |
| 9 | 2005 | 105 | |
| 10 | 2004 | 102 | |
| 11 | 2008 | 86 | |
| 12 | 1988 | 81 | |
| 13 | 1994 | 76 | |
| 14 | 2000 | 73 | |
| 15 | 2017 | 69 | |
| 16 | Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors. | 2003 | 53 |
| 17 | 2004 | 43 | |
| 18 | 1999 | 43 | |
| 19 | 1995 | 41 | |
| 20 | Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons. | 1996 | 40 |
About Hakim Bouterfa
Hakim Bouterfa is a scholar working on Epidemiology, Molecular Biology, Oncology, Neurology and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (16 papers), Neuroblastoma Research and Treatments (9 papers), Lung Cancer Research Studies (8 papers), Retinoids in leukemia and cellular processes (4 papers), Estrogen and related hormone effects (3 papers), Epigenetics and DNA Methylation (3 papers), Cell Adhesion Molecules Research (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Neurology (541 citations), Epidemiology (1.0k citations), Oncology (825 citations), Endocrinology, Diabetes and Metabolism (360 citations) and Radiology, Nuclear Medicine and Imaging (407 citations). Hakim Bouterfa has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include K. Roosen, Detlef Doenecke, François Jamar, Larry K. Kvols, Raffaella Barone, Roelf Valkema, Eric P. Krenning, Jens Kaufmann, Damian Wild and Guillaume Nicolas. Their work appears in journals such as Journal of Nuclear Medicine, Cancer Biotherapy and Radiopharmaceuticals, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Neuro-Oncology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.